Inactivation of plasminogen activator inhibitor by oxidants
- 1 October 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 25 (21) , 6351-6355
- https://doi.org/10.1021/bi00369a001
Abstract
The rapidly acting plasminogen activator inhibitor (PAI) purified from cultured bovine aortic endothelial cells (BAEs) was inactivated during iodination with chloramine T and other oxidizing iodination systems. Inactivation was observed in the absence of iodine, suggesting that the loss of activity resulted from the oxidizing conditions employed. In an attempt to further study the nature of this inactivation, the PAI was treated with chloramine T under conditions that specifically oxidize methionine and cysteine residues. Both PAI inhibitory activity and the ability of the PAI to form complexes with tissue-type PA were decreased in a dose-dependent manner by such treatment. The PAI was more sensitive to oxidative inactivation than urokinase, elastase, and .alpha.1-protease inhibitor. Incubation of the chloramine T inactivated PAI with methionine sulfoxide peptide reductase in the presence of dithiothreitol (DTT) restored more than 90% of the PAI activity. The reductase is a DTT-dependent enzyme that specifically converts methionine sulfoxide to methionine. Little activity was restored by either the reductase or DTT alone. These results indicate that the oxidation of at least one critical methionine residue is responsible for the loss of PAI activity upon iodination. In this respect, the BAE PAI resembles .alpha.1-protease inhibitor, a well-characterized elastase inhibitor that also is inactivated by oxidants. Both inhibitors are members of the serine protease inhibitor superfamily (Serpins), and both have a methionine residue in their reactive center.This publication has 33 references indexed in Scilit:
- The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center.Journal of Biological Chemistry, 1979
- An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue cultureBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor.Journal of Biological Chemistry, 1978
- Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical veinThrombosis Research, 1978
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Synthesis of fibrinolytic activator and inhibitor by endothelial cellsProceedings of the National Academy of Sciences, 1977
- POSSIBLE MECHANISMS OF EMPHYSEMA IN SMOKERS - CIGARETTE-SMOKE CONDENSATE SUPPRESSES PROTEASE INHIBITION INVITROPublished by Elsevier ,1977
- Human alpha-1-proteinase inhibitor mechanism of action: Evidence for activation by limited proteolysisBiochemical and Biophysical Research Communications, 1976
- Purification of urokinase by affinity chromatographyBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976